Delivery Order SPE2DR25D9133-SPE2DR26FCFK7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in an unrestricted...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $13,516.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for yellow fever vaccine (YF-VAX) products. The delivery order, awarded on November 18, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $16,701.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. The award was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents one of numerous recent awards issued to DMS...
- The Defense Logistics Agency awarded a $111,352 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. This delivery order was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3...
- The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, indicating the award was made on a competitive basis. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,189.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,560,800 doses of the YF-VAX yellow fever vaccine to support the recurring medical supply needs of military health facilities. This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (IDC) with the DLA,...
- The Defense Logistics Agency awarded a $27,835.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,670.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, utilizes firm fixed-price terms and carries no set-aside designation, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,567.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in single-dose vials. The contract, designated as delivery order 4570055827, operates under a firm fixed-price structure with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $22,270.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in one-dose vials. The award, issued on October 27, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. No set-aside designation was utilized in this competitive procurement. DMS Pharmaceutical...
- SPE2DR25D9133Indefinite Delivery Contract
- SPE2DR25D9133-SPE2DR26FCFK7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,135.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of YF-VAX (Yellow Fever Vaccine) in 1-dose vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was awarded on November 18, 2025, with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group holds a single-award IDC designated as contract SPE2DR, valued at up to $499,999,999 with a completion date of December 31, 2036, encompassing a 30-month base period and three optional 30-month renewal periods. The company serves as a critical regional prime vendor contractor under PPV-G GEN V, authorized to supply a comprehensive range of pharmaceuticals including branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military medical operations globally. The company's demonstrated capability across multiple product categories and consistent performance on numerous prior delivery orders throughout October and November 2025 positions it as an established supplier within the federal military pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 11/18/25 |